# Aldeyra Therapeutics, Inc.: Form 8-K, filed Sep 3, 2024

- Company: [Aldeyra Therapeutics, Inc.](/companies/aldx.md) (CIK 1341235)
- Form: 8-K
- Filed: 2024-09-03
- Accepted by EDGAR: Sep 3, 2024, 09:02 ET
- Period: 2024-08-29
- Accession: 0001193125-24-211645
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1341235/000119312524211645/d862679d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1341235/000119312524211645/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1341235/000119312524211645/d862679d8k.htm

Filed Sep 3, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-211645. Last ingested by Listed: Nov 6, 2026, 14:45 ET. No prices; not investment advice.